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Phenyl--tert-butyl-nitrone and
Benzonidazole Treatment Controlled the
Mitochondrial Oxidative Stress and Evolution
of Cardiomyopathy in Chronic Chagasic Rats
Jian-Jun Wen, PHD,* Shivali Gupta, PHD,* Zhangjun Guan, MD,† Monisha Dhiman, PHD,*
David Condon,* Charles Lui, MD,† Nisha Jain Garg, PHD*‡§
Galveston, Texas
Objectives The purpose of this study was to determine the pathological importance of oxidative stress–induced injurious
processes in chagasic heart dysfunction.
Background Trypanosoma cruzi–induced inflammatory pathology and a feedback cycle of mitochondrial dysfunction and oxi-
dative stress may contribute to Chagas disease.
Methods Sprague-Dawley rats were infected with T. cruzi and treated with phenyl--tert-butylnitrone (PBN), an anti-
oxidant, and/or benzonidazole (BZ), an antiparasitic agent. We monitored myocardial parasite burden, oxidative
adducts, mitochondrial complex activities, respiration, and adenosine triphosphate synthesis rates, and inflam-
matory and cardiac remodeling responses during disease development. The cardiac hemodynamics was deter-
mined for all rats.
Results Benzonidazole (not PBN) decreased the parasite persistence and immune adverse events (proinflammatory cyto-
kine expression, -nicotinamide adenine dinucleotide phosphate oxidase and myeloperoxidase activities, and
inflammatory infiltrate) in chronically infected hearts. PBN  BZ (not BZ alone) decreased the mitochondrial re-
active oxygen species level, oxidative adducts (malonyldialdehyde, 4-hydroxynonenal, carbonyls), hypertrophic
gene expression (atrial natriuretic peptide, B-type natriuretic peptide, -skeletal actin), and collagen deposition
and preserved the respiratory chain efficiency and energy status in chronically infected hearts. Subsequently, LV
dysfunction was prevented in PBN  BZ-treated chagasic rats.
Conclusions BZ treatment after the acute stage decreased the parasite persistence and inflammatory pathology. Yet, oxida-
tive adducts, mitochondrial dysfunction, and remodeling responses persisted and contributed to declining cardiac
function in chagasic rats. Combination treatment (PBN  BZ) was beneficial in arresting the T. cruzi–induced in-
flammatory and oxidative pathology and chronic heart failure in chagasic rats. (J Am Coll Cardiol 2010;55:
2499–508) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.02.030g
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thagas disease is an emerging parasitic disease in developed
ountries. In endemic countries, 16 to 18 million people
re infected with Trypanosoma cruzi and at risk of disease
evelopment (1). In most patients, acute infection results in
onspecific clinical symptoms. Several years after that, 30%
o 40% of seropositive individuals develop progressive cha-
rom the Departments of *Microbiology and Immunology, †Internal Medicine-
ardiology, and ‡Pathology, §Institute for Human Infections and Immunity, Center
or Biodefense and Emerging Infectious Diseases, and Sealy Center for Vaccine
evelopment, University of Texas Medical Branch, Galveston, Texas. This work was
upported by a grant (AI054578) from the National Institutes of Health/National
nstitute of Allergy and Infectious Disease to Dr. Garg.t
Manuscript received July 28, 2009; revised manuscript received February 9, 2010,
ccepted February 15, 2010.asic cardiomyopathy with ventricular dilation, arrhythmia,
nd contractile dysfunction, leading to cardiac arrest and
atient’s death (2).
Several lines of evidence establish that a low level of
arasites remains in the host during the chronic disease
hase (3). Direct detection of parasites in autopsy specimens
nd myocardial biopsy specimens has been shown by im-
unohistochemical and immunofluorescence techniques (4)
nd polymerase chain reaction (PCR) (5). The reactivation
f acute infection and parasitemia has been noted after
mmunosuppression due to acquired immunodeficiency syn-
rome (6) or drug therapy (7). Blood transfusion and
ransplantation of infected organs obtained from asymp-
omatic individuals are major causes of T. cruzi transmission
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These studies indicated that par-
asite persistence results in consis-
tent activation of inflammatory
responses and the development
and/or propagation of patholog-
ical lesions in the heart.
We and others (9) have shown
that chagasic myocardia sustain
oxidative injuries. Phagocytes
(macrophages and neutrophils),
activated to control T. cruzi in-
fection, are a major source of
oxidative stress in the acutely in-
fected host. Further, myocardial
oxidative stress is enhanced due
to increased mitochondrial pro-
duction of reactive oxygen species
(ROS) during Chagas disease
(10). A compromised antioxi-
dant status in T. cruzi–infected
experimental animals (11) was
associated with enhanced oxida-
tive modification of cellular
(11,12) and mitochondrial pro-
teins and lipids (13). The plasma
and intraerythrocyte levels of
glutathione and glutathione per-
oxidase are decreased (14), and
glutathione disulfide and malo-
nyldialdehyde (MDA) contents
ncreased (15) in human chagasic patients. These studies
ndicated that oxidative injurious processes are of patholog-
cal significance in Chagas disease.
In this study, we aimed to evaluate the relative patholog-
cal importance of parasite persistence and oxidative injuri-
us processes in the progression of Chagas disease and
ardiac contractile dysfunction. Sprague-Dawley rats were
nfected with T. cruzi and treated with phenyl--tert-
utylnitrone (PBN), a nitrone-based antioxidant that scav-
nges a wide variety of free radical species and inhibits free
adical generation (16). Some of the infected rats were
reated with benzonidazole (BZ), which is currently the
reatment of choice for chagasic patients (17). We deter-
ined the efficacy of PBN intervention in reducing the
eneration or the effects of ROS and of BZ in controlling
arasite persistence and subsequently evaluated whether
hese treatments (individually or in combination) were
eneficial in preventing progressive chagasic pathology and
ardiac dysfunction in chronically infected rats.
ethods
etails are provided in the Online Appendix.
nimals and parasites. Sprague-Dawley rats (4 to 5 weeks
Abbreviations
and Acronyms
sk actin  -skeletal
actin
ANOVA  analysis of
variance
ANP  atrial natriuretic
peptide
ATP  adenosine
triphosphate
BNP  B-type natriuretic
peptide
BZ  benzonidazole
HNE  4-hydroxynonenal
LV  left ventricular
MDA  malonyldialdehyde
MPO  myeloperoxidase
NOX  -nicotinamide
adenine dinucleotide
phosphate oxidase
PBN  phenyl--tert-
butylnitrone
PCR  polymerase chain
reaction
P-V  pressure-volume
pyr/mal  pyruvate/malate
ROS  reactive oxygen
species
XOD  xanthine oxidaseld, Harlan Laboratories, Indianapolis, Indiana) were ac- nustomed to animal facility for 1 month and then infected
ith T. cruzi (SylvioX10/4, 50,000 trypomastigotes per rat,
ntraperitoneally). Rats were given PBN (1.3 mM, beginning
ay 0 throughout the course of infection) and/or BZ (0.7
M, beginning day 40 post-infection, for 3 weeks) in
rinking water. Tissue parasite burden was determined by
raditional and real-time PCR using T. cruzi 18SrDNA–
pecific oligonucleotides (18). The institutional Animal
are and Use Committee approved all animal experiments.
OS and adenosine triphosphate (ATP). The myocar-
ial and mitochondrial levels of ROS were determined
sing dihydroethidium and amplex red/horseradish peroxi-
ase fluorescent probes (19). Cryostat tissue sections were
tained with dihydroethidium to detect in situ ROS. The
TP level in tissue homogenates and isolated mitochondria
as determined by a luciferin/luciferase bioluminescence
ethod (19). Mitochondria were energized with pyr/mal
pyruvate/malate) and succinate to monitor the rates of
OS and ATP production.
ipid and protein oxidation. The MDA level was deter-
ined by a thiobarbituric acid reactive substances assay
20). Protein carbonyls were derivatized with 2,4-
initrophenylhydrazine and estimated by enzyme-linked
mmunosorbent assay (21) using a polyclonal anti-2,4-
initrophenylhydrazine antibody (Chemicon, Billerica,
assachusetts). Paraffin-embedded tissue sections (5 m)
ere subjected to immunostaining with an anti– 4-
ydroxynonenal (HNE) antibody (Alpha Diagnostics, San
ntonio, Texas), and images analyzed by light microscopy.
nflammation and tissue pathology. Formalin-fixed myo-
ardial tissue sections were stained with hematoxylin/eosin
r Masson’s trichrome and scored for myocarditis, fibrosis,
nd parasitic lesions (22). The enzymatic activities of
anthine oxidase (XOD), -nicotinamide adenine dinucle-
tide phosphate oxidase (NOX), and myeloperoxidase
MPO) were monitored by spectrophotometry and/or in-
el catalytic staining.
The myocardial mRNA levels for proinflammatory cyto-
ines and hypertrophy markers were determined by real-
ime reverse transcriptase PCR (18).
eart function. Rats were monitored for heart function
uring the acute (25 to 40 days post-infection) and chronic
150 days post-infection) stages of infection. After intra-
eritoneal injection of heparin (1,000 IU/kg) and adminis-
ration of anesthesia, tracheotomy was performed to facili-
ate breathing, and a conductance pressure-volume (P-V)
atheter (Scisense, Inc., London, Ontario, Canada) was
nserted into the left ventricle. Respiration (80 breaths/min,
l/min O2) was controlled through a tracheotomy cannula
onnected to a pressure-controlled respirator (RSP1002,
ent Scientific, Litchfield, Connecticut). The conductance
nd pressure signals were digitized, and the volume calibra-
ion of the conductance system was performed. Hemody-
amic measurements were made using emka cardiac P-V
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hurch, Virginia).
ata analysis. Data were expressed as mean  SD (9
nimals per group, triplicate observations per experiment),
nalyzed by SPSS software version 14.0 (SPSS, Inc., Chi-
ago, Illinois). Normally distributed data were analyzed by
he Student t test (comparison of 2 groups) and 1-way
nalysis of variance (ANOVA) with Tukey’s post-hoc test
comparison of multiple groups). Mann-Whitney and
ruskal-Wallis tests were used when data were not normally
istributed. Significance is shown by normal-versus-infected/
ntreated and #infected/untreated-versus-infected/treated
* #p  0.05, ** ##p  0.01, *** ###p  0.001).
esults
arasite burden. Semiquantitative PCR showed a sig-
ificant level of Tc18SrDNA signal in the myocardium of
cutely and chronically infected rats (Figs. 1A and 1B).
he extent of Tc18SrDNA amplification was similar in
he heart tissue of infected/PBN-treated and infected/
ntreated rats. In comparison, Tc18SrDNA-specific sig-
al was barely detectable in the myocardium of BZ-
reated/chronically infected rats. Specificity of the PCR
as confirmed by no amplification of Tc18SrDNA with
Figure 1 Tissue Burden of Trypanosoma cruzi in Infected Rats
Myocardial total DNA was used as a template, and T. cruzi 18SrDNA amplified by
cation of Tc18SrDNA PCR amplicons (28 cycles), normalized to rat glyceraldehyde-
as mean  SD (n  9; ###p  0.001). AH  acutely infected/untreated (25 days
chronically infected/untreated (150 days post-infection); CHP  chronically infec
PBN  BZ treated; NH  normal heart; PBN  phenyl--tert-butylnitrone.ormal rat DNA. Real-time PCR was used to obtain a
uantitative measure of parasite burden in infected rats.
ur data showed a 15-fold higher parasite burden in
cutely infected hearts compared with chronically in-
ected hearts (Fig. 1C). BZ treatment ( PBN) resulted
n 55% decrease in Tc18SrDNA signal in infected rats
Fig. 1C) (p  0.01 [ANOVA-Tukey’s]). These results
howed that BZ was effective in controlling the parasite
ersistence, and PBN alone had no effect on parasite
eplication and/or survival in the heart.
OS and oxidative damage. Fluorometric evaluation of
OS showed 72% and 63% increases in H2O2 levels in
he myocardial homogenates of acutely and chronically
nfected rats (Fig. 2A) (p  0.01 [t test]) that was not
ontrolled in infected/BZ-treated rats. When treated
ith PBN ( BZ), the enhanced level of H2O2 was
ontrolled by 96% in acute myocardium and by 49% to
3% in chronically infected hearts (Fig. 2A) (all p values
0.01 [t test/ANOVA-Tukey’s]). In situ studies verified
hese results. We noted a substantial DHE oxidation to
thidium red in the myocardial sections of acutely and
hronically infected rats that were not treated or treated
ith BZ only (Fig. 2B). Infected rats treated with PBN
 BZ) exhibited a significant decrease in ethidium
N/BZ)
, B) and real-time polymerase chain reaction (PCR) (C). Densitometric quantifi-
phate dehydrogenase (GAPDH), is shown in B. Data in all figures are presented
infection); AHP  acutely infected/PBN treated; BZ  benzonidazole; CH 
N treated; CHB  chronically infected/BZ treated; CHBP  chronically infected/( PB
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Effects of PBN and Benzonidazole in Chagas Disease June 1, 2010:2499–508uorescence during the acute and chronic stages of
nfection and disease development (Fig. 2B).
In agreement with ROS levels, the myocardial contents
f MDA and carbonyl adducts were increased by 75% and
89%, respectively, in the acutely infected rats and by 66%
nd 168%, respectively, in chronically infected rats (Figs. 3A
nd 3B) (p  0.001 [t test]). The PBN ( BZ) treatment
esulted in a decrease in myocardial MDA and carbonyl
ontents by 62% and 77%, respectively, in the acute stage
nd by 84% to 88% and 100%, respectively, in the chronic
tage (all p values 0.001 [t test/ANOVA-Tukey’s]). Rats
reated with BZ only exhibited a slight control of MDA
31% decrease) and no decrease in carbonyl adducts com-
ared with infected/untreated rats. Immunostaining showed
xtensive HNE adducts (intensity score: 2 to 3) in acutely and
hronically infected rats and in chronically infected/BZ-treated
ats (Fig. 3C). HNE adducts were significantly decreased
intensity score: 0 to 1) in the myocardium of PBN-treated
 BZ) rats at both acute and chronic stages of infection and
isease development (Fig. 3C). These data (Figs. 2 and 3)
howed that PBN (but not BZ) treatment decreased the ROS
evel and oxidative damage in the myocardium of infected rats.
itochondrial dysfunction. Cardiac mitochondria of in-
ected rats exhibited 41% to 43% and 54% to 58% decreases
n the CI (reduced nicotinamide adenine dinucleotide–
uinone oxidoreductase) and CIII (cytochrome-c oxi-
Figure 2 Reactive Oxygen Species
Determination in Chagasic Rats ( PBN/BZ)
(A) The myocardial H2O2 levels were determined by the amplex red/horserad-
ish peroxidase method. (B) Frozen myocardial sections were loaded with dihy-
droethidium (oxidizes to fluorescent ethidium), and micrographs obtained at
20 magnification. ***p  0.001; ## **p  0.01; #p  0.05. Abbreviations
as in Figure 1.oreductase) respiratory complex activities, respectively, curing the course of infection and disease development
Figs. 4A and 4B) (p  0.01 [t test]). The respiratory chain
nefficiency was associated with enhanced mitochondrial
OS production. The pyr/mal- and succinate-stimulated
itochondrial ROS production was distinctly increased in
nfected myocardium (acute: 2-fold and 95%, respectively;
hronic: 1.8-fold and 91%, respectively) (Fig. 4C) (p 
.001 [t test]). Treatment with PBN ( BZ) resulted in
0% and 43% to 88% improvement in CI activity in acutely
nd chronically infected rats, respectively (Fig. 4A) and nor-
alization of CIII activity in infected myocardium (Fig. 4B).
ubsequently, pyr/mal- and succinate-dependent ROS forma-
ion was significantly controlled in PBN-treated ( BZ) rats
uring acute (82% and 96% decrease, respectively) and chronic
57% and 32% decrease, respectively) stages (Fig. 4C) (all
values 0.001 [t test/ANOVA-Tukey’s]). Treatment with
Z alone failed to preserve the respiratory complex activities or
vert the increased rate of ROS production in cardiac mito-
hondria of infected rats.
The pyr/mal- and succinate-dependent mitochondrial
ate of ATP synthesis was decreased by 54% to 57% in
nfected myocardium (Fig. 4D), and associated with 68% to
0% and 52% to 62% decreases in mitochondrial and
yocardial ATP levels, respectively (Figs. 4E and 4F). PBN
reatment ( BZ) improved the pyr/mal- and succinate-
ependent mitochondrial ATP production by 49% to 61%
n infected hearts (Fig. 4E) (all p values 0.01 [t test/
NOVA-Tukey’s]). Subsequently, mitochondrial and car-
iac ATP contents were improved in PBN-treated ( BZ)
ats by 35% to 46% (Figs. 4E and 4F) (all p values 0.01
t test/ANOVA-Tukey’s]). Treatment with BZ alone re-
ulted in no significant improvement in mitochondrial ATP
ynthesis and myocardial ATP levels in infected rats (Figs.
D to 4F). These data (Fig. 4) demonstrated that PBN (but
ot BZ) preserved the mitochondrial respiratory chain
ctivity and ATP production and prevented enhanced ROS
ormation in the myocardium of acutely and chronically
nfected rats.
BZ kills T. cruzi via oxidative stress (23) and thereby may
ave standby effects on host mitochondria. To determine
hether such is the case, we compared myocardial mito-
hondrial respiration in normal and normal/BZ-treated rats.
e observed no significant differences in the rate of
ubstrate-stimulated oxygen consumption in left ventricle
lices (in vivo) of normal and normal/BZ-treated rats.
ikewise, state 3 respiration and state 3/state 4 ratio of
solated cardiac mitochondria from normal/BZ-treated were
ot compromised (Online Fig. 1, Online Table 2). Further,
Z-treated/normal rats exhibited no significant increase in
DA and carbonyl adducts (data not shown). Thus, BZ
lone did not contribute to mitochondrial dysfunction and
xidative stress in the host myocardium.
nflammatory pathology. Histological studies showed par-
sitic foci and intense inflammatory infiltrate composed of
ononuclear (macrophages, T cells) and polymorphonu-lear (neutrophils) cells in acute myocardium (histological
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June 1, 2010:2499–508 Effects of PBN and Benzonidazole in Chagas Diseasecore 2 to 4) (Fig. 5A). The inflammatory sequel was
oderate and diffused in chronically infected hearts
histological score 1 to 2). The mRNA levels for proin-
ammatory cytokines interleukin-1, interferon gamma,
nd tumor necrosis factor- were significantly increased
n acutely and chronically infected myocardium (Figs. 5B
hrough 5D; all p values 0.001 [t test]). PBN treatment
f infected rats resulted in a moderate decrease in
yocardial inflammatory infiltrate (histological score 2 to
) and marginal to no change in cytokine mRNA levels.
n comparison, infected rats treated with BZ ( PBN)
xhibited a considerable decrease in myocardial inflam-
atory infiltrate (histological score 0 to 1). Accordingly,
he myocardial mRNA levels for interleukin-1, inter-
eron gamma, and tumor necrosis factor- were signifi-
antly decreased in chronically infected rats treated with
Z only (100%, 99%, and 89.5% decrease, respectively;
 0.01 [ANOVA-Tukey’s]) or treated with a combi-
ation of PBN and BZ (normalized to normal control
evel; p  0.01 [ANOVA-Tukey’s]) (Fig. 5).
NOX, MPO, and XOD are indicators of macrophage,
eutrophil, and endothelial cell activation, respectively.
pectrophotometric studies showed a substantial increase in
Figure 3 Myocardial Oxidative Damage in Trypanosoma cruzi–In
(A) Thiobarbituric acid reactive substances assay determination of myocardial mal
were measured by enzyme-linked immunosorbent assay. (C) Immunohistochemica
cation 40). *** ###p  0.001; #p  0.05.OX, MPO, and XOD activities in the infected myocar- aium (acute: 7.6-, 3.2-, and 43.1-fold increase, respectively;
hronic: 110%, 2.2-fold, and 108% increase, respectively)
Figs. 5E to 5G) (p 0.01 [t test]). PBN treatment ( BZ)
ed to a significant control of NOX and MPO activities in
he acute (60% to 70% and 63%, respectively, all p values
0.01 t test]) and chronic (55% to 95% and 58% to 71%,
espectively; all p values 0.01 [ANOVA-Tukey’s]) hearts.
ikewise, BZ treatment was effective and resulted in 16% to
5% decrease in NOX and 25% to 71% decrease in MPO
ctivities, respectively, in chronically infected myocardium
p  0.01 [ANOVA-Tukey’s]). PBN and BZ treatments
individually or in combination) did not alter the XOD
ctivity in infected rats (Fig. 5G). In-gel catalytic staining
ssays validated the spectrophotometric results and showed
hat PBN and BZ (individually or in combination) con-
rolled the enhanced activities of NOX and MPO in
nfected myocardium (Online Fig. 2). These data demon-
trated that the parasite-dependent infiltration of inflam-
atory infiltrate and cytokine expression in the heart were
ignificantly controlled by BZ. PBN was primarily effective
n limiting the inflammatory oxidative stress in chagasic
earts as evidenced by a decrease in NOX and MPO
ed Rats ( PBN/BZ)
ldehydes (MDA). (B) 2,4-dinitrophenylhydrazine–derivatized carbonyl proteins
ing of heart tissue sections with anti–4-hydroxynonenal (HNE) antibody (magnifi-fect
onlydia
l stainctivities.
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Effects of PBN and Benzonidazole in Chagas Disease June 1, 2010:2499–508ardiac remodeling. We performed Masson’s trichrome
taining of heart sections to detect collagen deposition. In
cutely infected rats, scattered foci of myocyte necrosis
ssociated with inflammatory cells were visible; however, no
ignificant evidence of fibrosis was detectable (Fig. 6A).
istological observation of extensive collagen deposition in
hronically infected rats (histological score 2 to 4) was
ssociated with a 10.4-, 4.4-, and 11.2-fold increase in
NP, BNP, and sk actin mRNAs, respectively (Figs. 6B to
D) (all p values 0.001 [t test]). We observed a moderate
ecrease (histological score 2 to 3) in collagen deposition
Fig. 6A), and a distinct decrease in the enhanced ANP,
Figure 4 Mitochondrial Functional Analysis in Chagasic Rats (
Spectrophotometric measurement of complex I (A) and complex III (B) activities in
(D) production was monitored in pyruvate/malate (pyr/mal)- and succinate (succ)-e
levels were determined by a luciferin/luciferase bioluminescence method. *** ##NP. and sk actin mRNA levels in infected rats treated dith PBN (82%, 77%, and 92%, respectively) or PBN/BZ
79.7%, 72.5%, and 74.8%, respectively) (Figs. 6B to 6D)
all p values 0.00 [t test/ANOVA-Tukey’s]). Treatment
ith BZ alone resulted in a marginal decrease in collagen
eposition (histological score 3 to 4) and BNP and sk actin
RNAs in chronically infected myocardium. These results
uggested that adjunct therapy with PBN and BZ was
ffective in limiting cardiac remodeling responses in cha-
asic rats.
emodynamic measurements. P-V loops were analyzed
t steady state and after inferior vena cava occlusion (Online
able 3). Baseline measurements showed no significant
N/BZ)
ted cardiac mitochondria. The rate of H2O2 (C) and adenosine triphosphate (ATP)
ed isolated cardiac mitochondria. The mitochondrial (E) and myocardial (F) ATP
.001; ##p  0.01. Abbreviations as in Figure 1.PB
isola
nergiz
#p  0ifferences in the hemodynamics of normal and acute rats
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June 1, 2010:2499–508 Effects of PBN and Benzonidazole in Chagas Diseasedata not shown). The pressure shifts of the P-V loops from
aseline (mm Hg: normal, 82.3; chronically infected, 48.1)
ndicated a decrease in cardiac contractility in the chronic
tage. The left ventricular (LV) dP/dtmax (peak rate of
ressure rise), dP/dtmax (peak rate of pressure decline),
troke volume (blood volume pumped with each beat),
ardiac output (blood volume pumped per minute), ejection
raction (fraction of blood ejected/contraction), and heart
Figure 5 Cardiac Inflammatory Response in Trypanosoma cruzi
(A) Hematoxylin and eosin staining of heart sections (blue nuclear and pink musc
and tumor necrosis factor (TNF)- (D) mRNAs, determined by real-time reverse tra
dinucleotide phosphate oxidase (NOX) (E), myleoperoxidase (MPO) (F), and xanthi
##p  0.01; #p  0.05. Abbreviations as in Figure 1.ate were decreased by 28%, 43%, 13%, 46%, 34%, and 38%, vespectively, in chronically infected rats (all p values 0.01
Mann-Whitney]). Notable elevation in end-systolic volume
nd end-diastolic volume occurred in chronically infected
earts with 174% and 44% increase, respectively, compared
ith controls. No significant gain in cardiac function was
bserved in chronically infected/BZ-treated rats. In compari-
on, a gain in cardiac function with PBN treatment was evident
y a significant elevation of dp/dtmax, dp/dtmax, stroke
ted Rats ( PBN/BZ)
plasm/keratin). Myocardial levels of interleukin (IL)-1 (B), interferon (IFN)- (C),
ase polymerase chain reaction. Specific activities of -nicotinamide adenine
ase (XOD) (G) were measured by spectrophotometry. *** ###p  0.001;–Infec
le/cyto
nscript
ne oxidolume, cardiac output, ejection fraction, and heart rate in
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Effects of PBN and Benzonidazole in Chagas Disease June 1, 2010:2499–508hronically infected, PBN-treated rats (48%, 59%, 26%, 70%,
3%, and 87%, respectively; all p values 0.01 [Kruskal-
allis]) and PBN/BZ-treated rats (52%, 53%, 100%, 96%,
1%, and 90%, respectively; all p values 0.001 [Kruskal-
allis]). Subsequently, end-systolic volume and end-diastolic
olume elevation noted in chronic chagasic hearts was normal-
zed to control level by PBN ( BZ) treatment (all p values
0.01 [Kruskal-Wallis]).
P-V loops with inferior vena cava occlusion showed that
he end-systolic P-V relationship (indicator of systolic
erformance) was decreased by 48% and the end-diastolic
-V relationship (indicator of diastolic stiffness) was in-
reased by 68% in chronically infected rats, and no benefit
as afforded by BZ treatment. PBN treatment ( BZ) was
eneficial as evidenced by 10% decrease in end-systolic
-V relationship and 15% increase in end-diastolic P-V
Figure 6 Myocardial Remodeling in Trypanosoma cruzi–Infected
(A) Masson’s trichrome staining of heart sections (blue collagen, red muscle/cyto
myocardial mRNA levels for atrial natriuretic peptide (ANP) (B), brain-natriuretic-pe
##p  0.01. Abbreviations as in Figure 1.elationship compared with normal controls. Thus, hemo- iynamic results showed that PBN markedly prevented the
hagasic cardiac dysfunction.
iscussion
n this study, we demonstrate that decreasing the oxidative
tress-induced alterations in myocardial structure, gene
xpression, and mitochondrial function is beneficial in
reventing the chronic evolution of cardiac dysfunction in
hagas disease. We also provide molecular and biochemical
vidence of the inefficacy of BZ during chronic Chagas
isease.
We used a rodent model of infection and disease devel-
pment that exhibited the classic hallmarks of chronic
hagas disease. Infected rats showed a high level of acute
arasite burden (Fig. 1), resulting in extensive infiltration of
s ( PBN/BZ)
). Real-time reverse transcriptase polymerase chain reaction measurement of
BNP) (C), and -skeletal actin (sk-Actin) (D). *** ###p  0.001; #p  0.05;Rat
plasm
ptide (nflammatory infiltrate and expression of proinflammatory
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June 1, 2010:2499–508 Effects of PBN and Benzonidazole in Chagas Diseaseytokines in the heart (Fig. 5). During the chronic stage,
iffused inflammatory response persisted in the heart. Car-
iac remodeling in chronically infected rats was evi-
enced by an increased expression of hypertrophy mark-
rs (ANP, BNP, and sk actin) and collagen deposition
Fig. 6). Subsequently, ventricular performance was com-
romised, as evidenced by 34% to 46% decrease in cardiac
utput and ejection fraction and alterations in other
arameters proposed as a fair index of contractility
Online Table 3) (24). The baseline hemodynamics of
hronically infected rats, obtained with the P-V loops,
ere in accordance with the results from human chagasic
atients (25).
A systematic review of the literature indicates that the
athogenesis of Chagas disease is dependent on a low-
rade, systemic infection with documented immune system
dverse reactions (discussed in Sack et al. [3]). Only acutely
nfected patients, irrespective of their ages, are shown to
espond to treatment with an antiparasite drug (BZ) and be
ured, defined by the control of acute parasitemia and
yocarditis (17). No convincing evidence exists demon-
trating the efficacy of BZ in chronically infected patients.
urther, it is not known whether drug therapies are inef-
ective in chronically infected patients because either BZ
ails to kill tissue parasites or other host events persist
ndependent of parasites and result in the evolution of
hronic heart failure. To investigate this, we examined in
ur experimental model the effect of BZ treatment on
arasites and host events. Our data showed that oral delivery
f BZ for 3 weeks during an indeterminate phase precluded
he tissue parasite persistence and associated inflammation
n chronically infected hearts (Figs. 1 and 5). Activated
eutrophils and macrophages express NOX, inducible nitric
xide synthase, and MPO and participate in parasite control
hrough a release of cytotoxic ROS, nitric oxide, and HOCl,
espectively (26). Our observation of a decrease in NOX and
PO activities (Fig. 5, Online Fig. 2) in BZ-treated
hronically infected rats provided further evidence that
ntiparasite therapy was effective in averting the parasite-
ediated inflammatory pathology. Nonetheless, BZ-
reated/chronically infected rats exhibited cardiac remodel-
ng (Fig. 6) and deterioration of ventricular contractility
Online Table 3) comparable to that exhibited by untreated/
hronically infected rats. These data provide molecular
vidence that a lack of control of chronic Chagas disease by
Z is not due to its inefficacy in controlling parasite
ersistence and parasite-dependent inflammatory responses.
mportantly, the observations in BZ-treated rats of consis-
ent oxidative stress–induced myocardial adducts (Fig. 3)
nd mitochondrial inefficiency (Fig. 4) strongly indicate a
ole of oxidative stress and mitochondrial/cellular injuries in
V dysfunction during progressive Chagas disease. The
itochondrial production of ROS was significantly en-
anced in BZ-treated and untreated chronically infected
ats (Fig. 4), thus, providing evidence of the mitochondrial
rigin of pathological oxidative stress in chagasic hearts. (PBN treatment of infected rats provided direct evidence
f the detrimental effects of oxidative stress and mitochon-
rial dysfunction in Chagas disease. Oral delivery of PBN
 BZ) resulted in preservation of LV function (Online
able 3). It is important to note that beneficial effects of
BN in preserving cardiac function were observed despite
o decline in parasite persistence (Fig. 1) and moderate to
o change in myocardial inflammatory infiltrate and proin-
ammatory cytokines in chronically infected hearts (Fig. 5).
nstead, PBN-treated/chronically infected rats exhibited a
ubstantial increase in mitochondrial function as evidenced
y improved complex activities and ATP synthesis and
ecreased ROS production (Fig. 4). The decrease in mito-
hondrial ROS levels was associated with a significant
ecrease in the myocardial accumulation of MDA, HNE,
nd carbonyls adducts in PBN-treated/chronically infected
ats (Fig. 3). The maximal benefits were obtained when rats
ere treated with PBN and BZ in combination; thus,
uggesting that combinatorial therapies, including antipar-
sitic drugs and antioxidants, will be effective in preserving
he LV function in chagasic hearts.
Cardiac hypertrophy is a key phenotype of the failing
eart and a major independent risk factor predictive of
ardiovascular mortality and morbidity. In both experimen-
al models and human chagasic patients, clinical evolution
f heart failure is preceded by anatomopathological changes
hat include ventricular thickness and interstitial fibrosis,
ollowed by ventricular dilation and reduced contractility
27). The re-expression of fetal genes (ANP, BNP, sk actin,
nd -MHC) is a hallmark of hypertrophic remodeling, and
considerable body of evidence shows the redox regulation
f remodeling responses in cardiac diseases of various
tiologies (28). Besides ROS, experimental studies have
hown that the inflammatory cytokines, tumor necrosis
actor-, interleukin-1, and monocyte chemoattractant
rotein 1, also promote myocardial hypertrophy and con-
ribute to the development and progression of heart failure
29). Our observation of a decrease in the expression of
ypertrophic markers and collagen deposition in response to
BN treatment ( BZ) (Fig. 6) suggests that ROS signals
ypertrophic remodeling in chagasic myocardium. The role
f ROS of mitochondrial, but not of inflammatory, origin in
ignaling hypertrophy in chagasic hearts is provided by the
bservation that NOX and MPO, the classic mediators of
nflammatory ROS, were equally depressed in BZ- and
BN-treated rats (Fig. 5), and yet hypertrophic phenotype
as depressed in PBN-treated rats only (Fig. 6). Further
tudies would identify whether inflammatory cytokines
ynergistically enhance the ROS-mediated signaling cas-
ades involved in activation of hypertrophic responses in
hagasic hearts.
tudy limitations. We acknowledge the limitations of the
odent model system used in the current study, and the
hort time-period during which animals were monitored.
urther long-term studies are required in larger mammalse.g. dogs, baboons) that more accurately mimic the human
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Effects of PBN and Benzonidazole in Chagas Disease June 1, 2010:2499–508ymptoms and progression of Chagas disease to validate the
otential benefits of adjunct therapies in preventing chronic
volution of Chagas disease.
onclusions
e have shown that complex inflammatory and oxidative
rocesses in the heart contribute to the evolution of chronic
ypertrophy and LV dysfunction in Chagas disease. Specif-
cally, PBN treatment enhanced the antioxidant/oxidant
alance, preserved the mitochondrial respiratory chain ac-
ivity and ATP synthesis, and averted the ROS-induced
ypertrophy and LV dysfunction in chronically infected
ats. BZ treatment was effective in controlling parasite
ersistence and associated inflammation, but the feedback
ycle of mitochondrial dysfunction and oxidative stress
ersisted, and, therefore, LV function was not significantly
mproved in BZ-treated/chronically infected rats. Thus, we
ropose that a combination of antioxidants capable of
odulating or delaying the onset of oxidative insult and
itochondrial deficiencies and anti-parasite drugs capable
f abolishing parasites and parasite-associated inflammation
n the myocardium would prove beneficial in preventing
ardiac pathology and loss of LV function in Chagas
isease.
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APPENDIX
or details of the methods and supplemental figures and tables, please see
he online version of this article.
